Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Precision Biosciences (DTIL) Other Non-Current Liabilities (2020 - 2025)

Precision Biosciences (DTIL) has disclosed Other Non-Current Liabilities for 6 consecutive years, with $4.0 million as the latest value for Q3 2025.

  • On a quarterly basis, Other Non-Current Liabilities fell 59.74% to $4.0 million in Q3 2025 year-over-year; TTM through Sep 2025 was $4.0 million, a 59.74% decrease, with the full-year FY2024 number at $2.8 million, up 2084.38% from a year prior.
  • Other Non-Current Liabilities was $4.0 million for Q3 2025 at Precision Biosciences, up from $200000.0 in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $10.0 million in Q2 2021 to a low of $128000.0 in Q4 2023.
  • A 5-year average of $6.2 million and a median of $10.0 million in 2021 define the central range for Other Non-Current Liabilities.
  • Peak YoY movement for Other Non-Current Liabilities: plummeted 98.72% in 2023, then soared 4925.13% in 2024.
  • Precision Biosciences' Other Non-Current Liabilities stood at $10.0 million in 2021, then changed by 0.0% to $10.0 million in 2022, then tumbled by 98.72% to $128000.0 in 2023, then soared by 2084.38% to $2.8 million in 2024, then skyrocketed by 43.99% to $4.0 million in 2025.
  • Per Business Quant, the three most recent readings for DTIL's Other Non-Current Liabilities are $4.0 million (Q3 2025), $200000.0 (Q2 2025), and $10.0 million (Q1 2025).